1 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 23.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 12283377 2023-04-01 2024-03-31 12283377 2024-03-31 12283377 2023-03-31 12283377 2022-04-01 2023-03-31 12283377 2023-03-31 12283377 2022-03-31 12283377 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12283377 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 12283377 bus:Director1 2023-04-01 2024-03-31 12283377 core:WithinOneYear 2024-03-31 12283377 core:WithinOneYear 2023-03-31 12283377 core:ShareCapital 2024-03-31 12283377 core:ShareCapital 2023-03-31 12283377 core:RetainedEarningsAccumulatedLosses 2024-03-31 12283377 core:RetainedEarningsAccumulatedLosses 2023-03-31 12283377 bus:OrdinaryShareClass1 core:ShareCapital 2024-03-31 12283377 bus:OrdinaryShareClass1 core:ShareCapital 2023-03-31 12283377 bus:OrdinaryShareClass2 core:ShareCapital 2024-03-31 12283377 bus:OrdinaryShareClass2 core:ShareCapital 2023-03-31 12283377 bus:SmallEntities 2023-04-01 2024-03-31 12283377 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 12283377 bus:FullAccounts 2023-04-01 2024-03-31 12283377 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 12283377 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31
Company registration number: 12283377
APPANNA HEALTHCARE LTD
Unaudited filleted financial statements
31 March 2024
APPANNA HEALTHCARE LTD
Contents
Balance sheet
Notes to the financial statements
APPANNA HEALTHCARE LTD
Balance sheet
31 March 2024
2024 2023
Note £ £ £ £
Current assets
Debtors 5 2,178 3,678
Cash at bank and in hand 67,353 45,371
_______ _______
69,531 49,049
Creditors: amounts falling due
within one year 6 ( 12,825) ( 10,810)
_______ _______
Net current assets 56,706 38,239
_______ _______
Total assets less current liabilities 56,706 38,239
_______ _______
Net assets 56,706 38,239
_______ _______
Capital and reserves
Called up share capital 7 103 103
Profit and loss account 56,603 38,136
_______ _______
Shareholders funds 56,706 38,239
_______ _______
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 23 December 2024 , and are signed on behalf of the board by:
Dr T Appanna
Director
Company registration number: 12283377
APPANNA HEALTHCARE LTD
Notes to the financial statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in United Kingdom. The address of the registered office is Clifton House, Four Elms Road, Cardiff, CF24 1LE.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. all of the financial instruments applying to the company are basic as defined in the Accounting Standard, and as such are initially recognised at the transaction price. Debt instruments are subsequently measured at amortised cost.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Debtors
2024 2023
£ £
Trade debtors 2,178 3,678
_______ _______
6. Creditors: amounts falling due within one year
2024 2023
£ £
Social security and other taxes 5,036 5,559
Director loan accounts 7,009 4,471
Other creditors 780 780
_______ _______
12,825 10,810
_______ _______
7. Called up share capital
Issued, called up and fully paid
2024 2023
No £ No £
Ordinary shares of £ 1.00 each 100 100 100 100
Ordinary A shares of £ 1.00 each 3 3 3 3
_______ _______ _______ _______
103 103 103 103
_______ _______ _______ _______